Advanced Robotic Clot Manipulation and Removal Systems

This inventive concept envisions a next-generation robotic system for clot manipulation and removal, leveraging AI-assisted navigation, real-time imaging feedback, and advanced haptic feedback to optimize treatment outcomes and revolutionize the field of vascular medicine.

The original patent disclosed a robotically controlled system for clot removal, but it had limitations in terms of navigation, precision, and adaptability. The new inventive concept addresses these limitations by incorporating cutting-edge technologies to provide more effective and efficient clot removal procedures.

The advanced robotic system features AI-assisted navigation, which enables real-time tracking of the clot and optimal instrument positioning. The system also incorporates real-time imaging feedback, allowing for precise monitoring of the procedure and instant adjustments. Additionally, the system includes advanced haptic feedback, enabling the physician to remotely manipulate the instrument with enhanced precision and tactile sensitivity. The system can be configured to accommodate varying clot sizes and shapes through a dynamically adjustable working channel.

The new inventive concept introduces a paradigm shift in clot removal technology by integrating AI-assisted navigation, real-time imaging feedback, and advanced haptic feedback. These features, combined with the dynamically adjustable working channel, provide a significant improvement over the original patent and make the new system more effective, efficient, and adaptable.

Alternative embodiments of the inventive concept could include the use of swarm robotics, where multiple micro-robots are deployed to disintegrate and evacuate the clot. Another variation could involve the development of a cloud-based platform for remote clot removal procedures, enabling real-time collaboration and consultation between medical professionals.

The advanced robotic clot manipulation and removal system has significant commercial potential in the vascular medicine market, particularly in the areas of stroke treatment, peripheral artery disease, and pulmonary embolism. The system's ability to optimize treatment outcomes and reduce procedure times could lead to increased adoption and market share.